# MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)

> **NCT04004559** · — · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 600 (estimated)

## Conditions studied

- Invasive Breast Cancer
- Neoadjuvant Chemotherapy
- Radiomics
- Axillary Lymph Node
- Prognosis

## Interventions

- **OTHER:** No interventions

## Key facts

- **NCT ID:** NCT04004559
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-28
- **Primary completion:** 2020-10-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-06-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04004559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04004559, "MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04004559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*